MR Spectroscopy (MRS) can provide chemical composition of in vivo tissue non-invasively. Detection of signature chemical composition in tumors which are expected based on knowledge of histopathology could enable discrimination between tumor subtypes and grade by MRS. In this feasibility study we demonstrate ability to perform with success renal MRS in health volunteers mapping normal signature composition of renal tissue and provide a platform to expand the work to renal cancer tumor composition mapping and discrimination therewith based on metabolite content.
This abstract and the presentation materials are available to members only; a login is required.